Remedy Pharmaceuticals Receives $9,000,000 New Funding

  • Feed Type
  • Date
    12/1/2015
  • Company Name
    Remedy Pharmaceuticals
  • Mailing Address
    122 West 27th Street 10th Floor New York, NY 10001 USA
  • Company Description
    Remedy Pharmaceuticals, Inc. is a clinical stage company developing small molecule drugs targeting NCCa-ATP channels in acute central nervous system injury including traumatic brain injury, stroke, and spinal cord injury.
  • Website
    http://www.remedypharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Funds will be used to accelerate the company’s pathway to a phase 3 study in severe stroke.
  • M&A Terms
  • Venture Investor
    The Vertical Group
  • Venture Investor
    Undisclosed

Trending on Xconomy